Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
8.49
+0.01 (0.12%)
Sep 4, 2026, 3:00 PM CST
SHA:600420 Market Cap
SHA:600420 has a market cap or net worth of 11.39 billion as of September 4, 2026. Its market cap has decreased by -25.66% in one year.
Market Cap
11.39B
Enterprise Value
10.05B
Revenue
8.43B
Ranking
n/a
PE Ratio
20.89
Stock Price
8.49
ChartMarket Cap Chart
Since August 23, 2004, SHA:600420's market cap has increased from 833.55M to 11.39B, an increase of 1,266.03%. That is a compound annual growth rate of 12.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 11.39B | -15.94% |
| Dec 31, 2025 | 13.55B | -15.41% |
| Dec 31, 2024 | 16.01B | 21.96% |
| Dec 29, 2023 | 13.13B | 40.50% |
| Dec 30, 2022 | 9.35B | -12.25% |
| Dec 31, 2021 | 10.65B | 9.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tibet Rhodiola Pharmaceutical Holding Co. | 12.12B |
| Guobang Pharma | 12.03B |
| Wedge Industrial | 12.02B |
| Zhejiang Medicine | 12.02B |
| Zhejiang CONBA Pharmaceutical | 11.14B |
| Shenzhen Chipscreen Biosciences | 11.14B |
| Henan Lingrui Pharmaceutical | 11.12B |
| Beijing Aosaikang Pharmaceutical | 10.86B |